These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16412625)

  • 1. Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients.
    van de Garde EM; Souverein PC; van den Bosch JM; Deneer VH; Goettsch WG; Leufkens HG
    Respir Med; 2006 Aug; 100(8):1342-8. PubMed ID: 16412625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining length of hospital stay for pneumonia and postdischarge outcomes.
    Capelastegui A; España PP; Quintana JM; Gallarreta M; Gorordo I; Esteban C; Urrutia I; Bilbao A
    Am J Med; 2008 Oct; 121(10):845-52. PubMed ID: 18823851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia.
    Ramirez J; Aliberti S; Mirsaeidi M; Peyrani P; Filardo G; Amir A; Moffett B; Gordon J; Blasi F; Bordon J
    Clin Infect Dis; 2008 Jul; 47(2):182-7. PubMed ID: 18533841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
    Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors related to mortality of aged patients hospitalized with community-acquired pneumonia].
    Ramos Martínez A; Portero Navío JL; Sanz Carabaña P; Dols Juste J; Millán Santos I; Murillas Angoiti J; Gazapo Navarro T
    An Med Interna; 1998 Jul; 15(7):353-7. PubMed ID: 9710984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.
    Wenisch C; Krause R; Széll M; Laferl H
    Infection; 2006 Aug; 34(4):190-5. PubMed ID: 16896576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
    Serisier DJ; Bowler SD
    Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does socioeconomic status affect mortality subsequent to hospital admission for community acquired pneumonia among older persons?
    Vrbova L; Mamdani M; Moineddin R; Jaakimainen L; Upshur RE
    J Negat Results Biomed; 2005 Apr; 4():4. PubMed ID: 15819975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of length of stay between the young and aged in hospitalized community-acquired pneumonia patients.
    Kaysar M; Augustine T; Jim L; Benjamin C
    Geriatr Gerontol Int; 2008 Dec; 8(4):227-33. PubMed ID: 19149833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
    Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.